Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Decontamination of aerosolised bacteria from a pig farm environment using a pH neutral electrochemically activated solution (Ecas4 anolyte).

Tenzin S, Ogunniyi AD, Khazandi M, Ferro S, Bartsch J, Crabb S, Abraham S, Deo P, Trott DJ.

PLoS One. 2019 Sep 25;14(9):e0222765. doi: 10.1371/journal.pone.0222765. eCollection 2019.

2.

In vitro Antimicrobial Activity of Robenidine, Ethylenediaminetetraacetic Acid and Polymyxin B Nonapeptide Against Important Human and Veterinary Pathogens.

Khazandi M, Pi H, Chan WY, Ogunniyi AD, Sim JXF, Venter H, Garg S, Page SW, Hill PB, McCluskey A, Trott DJ.

Front Microbiol. 2019 Apr 25;10:837. doi: 10.3389/fmicb.2019.00837. eCollection 2019.

3.

Allicin prevents the formation of Proteus-induced urinary crystals and the blockage of catheter in a bladder model in vitro.

Imani Rad H, Peeri H, Amani M, Mohammadnia A, Ogunniyi AD, Khazandi M, Venter H, Arzanlou M.

Microb Pathog. 2019 Jul;132:293-301. doi: 10.1016/j.micpath.2019.05.016. Epub 2019 May 10.

PMID:
31082531
4.

Th17 responses to pneumococcus in blood and adenoidal cells in children.

Oliver E, Pope C, Clarke E, Langton Hewer C, Ogunniyi AD, Paton JC, Mitchell T, Malley R, Finn A.

Clin Exp Immunol. 2019 Feb;195(2):213-225. doi: 10.1111/cei.13225. Epub 2018 Oct 31.

PMID:
30325010
5.

Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.

Russell CC, Stevens A, Pi H, Khazandi M, Ogunniyi AD, Young KA, Baker JR, McCluskey SN, Page SW, Trott DJ, McCluskey A.

ChemMedChem. 2018 Dec 6;13(23):2573-2580. doi: 10.1002/cmdc.201800463. Epub 2018 Nov 19.

PMID:
30318716
6.

Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing.

Ogunniyi AD, Kopecki Z, Hickey EE, Khazandi M, Peel E, Belov K, Boileau A, Garg S, Venter H, Chan WY, Hill PB, Page SW, Cowin AJ, Trott DJ.

PLoS One. 2018 Jul 16;13(7):e0200195. doi: 10.1371/journal.pone.0200195. eCollection 2018.

7.

Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens.

Hickey EE, Wong HS, Khazandi M, Ogunniyi AD, Petrovski KR, Garg S, Page SW, O'Handley R, Trott DJ.

J Vet Pharmacol Ther. 2018 Oct;41(5):746-754. doi: 10.1111/jvp.12674. Epub 2018 Jul 4.

PMID:
29971788
8.

Genomic characterization of coagulase-negative staphylococci including methicillin-resistant Staphylococcus sciuri causing bovine mastitis.

Khazandi M, Al-Farha AA, Coombs GW, O'Dea M, Pang S, Trott DJ, Aviles RR, Hemmatzadeh F, Venter H, Ogunniyi AD, Hoare A, Abraham S, Petrovski KR.

Vet Microbiol. 2018 Jun;219:17-22. doi: 10.1016/j.vetmic.2018.04.004. Epub 2018 Apr 5.

PMID:
29778192
9.

Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.

Ogunniyi AD, Khazandi M, Stevens AJ, Sims SK, Page SW, Garg S, Venter H, Powell A, White K, Petrovski KR, Laven-Law G, Tótoli EG, Salgado HR, Pi H, Coombs GW, Shinabarger DL, Turnidge JD, Paton JC, McCluskey A, Trott DJ.

PLoS One. 2017 Sep 5;12(9):e0183457. doi: 10.1371/journal.pone.0183457. eCollection 2017.

10.

Efficacy evaluation of a new water sanitizer for increasing the shelf life of Southern Australian King George Whiting and Tasmanian Atlantic Salmon fillets.

Khazandi M, Deo P, Ferro S, Venter H, Pi H, Crabb S, Amorico T, Ogunniyi AD, Trott DJ.

Food Microbiol. 2017 Dec;68:51-60. doi: 10.1016/j.fm.2017.06.008. Epub 2017 Jun 19.

PMID:
28800825
11.

Proteomic comparisons of opaque and transparent variants of Streptococcus pneumoniae by two dimensional-differential gel electrophoresis.

Chai MH, Weiland F, Harvey RM, Hoffmann P, Ogunniyi AD, Paton JC.

Sci Rep. 2017 May 26;7(1):2453. doi: 10.1038/s41598-017-02465-x.

12.

The Pneumococcal Alpha-Glycerophosphate Oxidase Enhances Nasopharyngeal Colonization through Binding to Host Glycoconjugates.

Mahdi LK, Higgins MA, Day CJ, Tiralongo J, Hartley-Tassell LE, Jennings MP, Gordon DL, Paton AW, Paton JC, Ogunniyi AD.

EBioMedicine. 2017 Apr;18:236-243. doi: 10.1016/j.ebiom.2017.03.002. Epub 2017 Mar 3.

13.

Evaluation of a series of 2-napthamide derivatives as inhibitors of the drug efflux pump AcrB for the reversal of antimicrobial resistance.

Wang Y, Mowla R, Guo L, Ogunniyi AD, Rahman T, De Barros Lopes MA, Ma S, Venter H.

Bioorg Med Chem Lett. 2017 Feb 15;27(4):733-739. doi: 10.1016/j.bmcl.2017.01.042. Epub 2017 Jan 16.

PMID:
28129976
14.

Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine.

Babb R, Chen A, Ogunniyi AD, Hirst TR, Kara EE, McColl SR, Alsharifi M, Paton JC.

Clin Sci (Lond). 2017 Jan 1;131(2):169-180. doi: 10.1042/CS20160475. Epub 2016 Nov 24.

PMID:
27885052
15.

Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.

Babb R, Chen A, Hirst TR, Kara EE, McColl SR, Ogunniyi AD, Paton JC, Alsharifi M.

Clin Sci (Lond). 2016 May;130(9):697-710. doi: 10.1042/CS20150699. Epub 2016 Feb 1.

PMID:
26831937
16.

Robenidine Analogues as Gram-Positive Antibacterial Agents.

Abraham RJ, Stevens AJ, Young KA, Russell C, Qvist A, Khazandi M, Wong HS, Abraham S, Ogunniyi AD, Page SW, O'Handley R, McCluskey A, Trott DJ.

J Med Chem. 2016 Mar 10;59(5):2126-38. doi: 10.1021/acs.jmedchem.5b01797. Epub 2016 Feb 10.

PMID:
26765953
17.

Characterization of Pneumococcal Genes Involved in Bloodstream Invasion in a Mouse Model.

Mahdi LK, Van der Hoek MB, Ebrahimie E, Paton JC, Ogunniyi AD.

PLoS One. 2015 Nov 5;10(11):e0141816. doi: 10.1371/journal.pone.0141816. eCollection 2015.

18.

CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.

Kara EE, McKenzie DR, Bastow CR, Gregor CE, Fenix KA, Ogunniyi AD, Paton JC, Mack M, Pombal DR, Seillet C, Dubois B, Liston A, MacDonald KPA, Belz GT, Smyth MJ, Hill GR, Comerford I, McColl SR.

Nat Commun. 2015 Oct 29;6:8644. doi: 10.1038/ncomms9644.

19.

Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin.

Knippenberg S, Ueberberg B, Maus R, Bohling J, Ding N, Tort Tarres M, Hoymann HG, Jonigk D, Izykowski N, Paton JC, Ogunniyi AD, Lindig S, Bauer M, Welte T, Seeger W, Guenther A, Sisson TH, Gauldie J, Kolb M, Maus UA.

Thorax. 2015 Jul;70(7):636-46. doi: 10.1136/thoraxjnl-2014-206420. Epub 2015 May 11.

20.

Correction: Comparative GO: a web application for comparative gene ontology and gene ontology-based gene selection in bacteria.

Fruzangohar M, Ebrahimie E, Ogunniyi AD, Mahdi LK, Paton JC, Adelson DL.

PLoS One. 2015 Apr 17;10(4):e0125537. doi: 10.1371/journal.pone.0125537. eCollection 2015. No abstract available.

21.

Erratum for Le et al., Modulation of Adherence, Invasion, and Tumor Necrosis Factor Alpha Secretion during the Early Stages of Infection by Streptococcus pneumoniae ClpL.

Le NT, Jeong HY, Kwon HY, Ogunniyi AD, Paton JC, Pyo SN, Rhee DK.

Infect Immun. 2015 Mar;83(3):1224. doi: 10.1128/IAI.03125-14. No abstract available.

22.

Delayed reconstitution of B cell immunity to pneumococcus in HIV-infected Malawian children on antiretroviral therapy.

Iwajomo OH, Moons P, Nkhata R, Mzinza D, Ogunniyi AD, Williams NA, Heyderman RS, Finn A.

J Infect. 2015 Jun;70(6):616-23. doi: 10.1016/j.jinf.2014.10.011. Epub 2014 Nov 1.

23.

A random six-phase switch regulates pneumococcal virulence via global epigenetic changes.

Manso AS, Chai MH, Atack JM, Furi L, De Ste Croix M, Haigh R, Trappetti C, Ogunniyi AD, Shewell LK, Boitano M, Clark TA, Korlach J, Blades M, Mirkes E, Gorban AN, Paton JC, Jennings MP, Oggioni MR.

Nat Commun. 2014 Sep 30;5:5055. doi: 10.1038/ncomms6055.

24.

A functional genomics catalogue of activated transcription factors during pathogenesis of pneumococcal disease.

Mahdi LK, Deihimi T, Zamansani F, Fruzangohar M, Adelson DL, Paton JC, Ogunniyi AD, Ebrahimie E.

BMC Genomics. 2014 Sep 8;15:769. doi: 10.1186/1471-2164-15-769.

25.

AdcA and AdcAII employ distinct zinc acquisition mechanisms and contribute additively to zinc homeostasis in Streptococcus pneumoniae.

Plumptre CD, Eijkelkamp BA, Morey JR, Behr F, Couñago RM, Ogunniyi AD, Kobe B, O'Mara ML, Paton JC, McDevitt CA.

Mol Microbiol. 2014 Feb;91(4):834-51. doi: 10.1111/mmi.12504. Epub 2014 Jan 16.

26.

Impairment of pneumococcal antigen specific isotype-switched Igg memory B-cell immunity in HIV infected Malawian adults.

Iwajomo OH, Finn A, Ogunniyi AD, Williams NA, Heyderman RS.

PLoS One. 2013 Nov 4;8(11):e78592. doi: 10.1371/journal.pone.0078592. eCollection 2013.

27.

Vaccination against Streptococcus pneumoniae using truncated derivatives of polyhistidine triad protein D.

Plumptre CD, Ogunniyi AD, Paton JC.

PLoS One. 2013 Oct 31;8(10):e78916. doi: 10.1371/journal.pone.0078916. eCollection 2013.

28.

A transcription factor contributes to pathogenesis and virulence in Streptococcus pneumoniae.

Mahdi LK, Ebrahimie E, Adelson DL, Paton JC, Ogunniyi AD.

PLoS One. 2013 Aug 13;8(8):e70862. doi: 10.1371/journal.pone.0070862. eCollection 2013.

29.

Surface association of Pht proteins of Streptococcus pneumoniae.

Plumptre CD, Ogunniyi AD, Paton JC.

Infect Immun. 2013 Oct;81(10):3644-51. doi: 10.1128/IAI.00562-13. Epub 2013 Jul 22.

30.

Comparative GO: a web application for comparative gene ontology and gene ontology-based gene selection in bacteria.

Fruzangohar M, Ebrahimie E, Ogunniyi AD, Mahdi LK, Paton JC, Adelson DL.

PLoS One. 2013;8(3):e58759. doi: 10.1371/journal.pone.0058759. Epub 2013 Mar 11. Erratum in: PLoS One. 2015;10(4):e0125537.

31.

The effects of methionine acquisition and synthesis on Streptococcus pneumoniae growth and virulence.

Basavanna S, Chimalapati S, Maqbool A, Rubbo B, Yuste J, Wilson RJ, Hosie A, Ogunniyi AD, Paton JC, Thomas G, Brown JS.

PLoS One. 2013;8(1):e49638. doi: 10.1371/journal.pone.0049638. Epub 2013 Jan 22.

32.

FMS-like tyrosine kinase 3 ligand treatment of mice aggravates acute lung injury in response to Streptococcus pneumoniae: role of pneumolysin.

Brumshagen C, Maus R, Bischof A, Ueberberg B, Bohling J, Osterholzer JJ, Ogunniyi AD, Paton JC, Welte T, Maus UA.

Infect Immun. 2012 Dec;80(12):4281-90. doi: 10.1128/IAI.00854-12. Epub 2012 Sep 24.

33.

Polyhistidine triad proteins of pathogenic streptococci.

Plumptre CD, Ogunniyi AD, Paton JC.

Trends Microbiol. 2012 Oct;20(10):485-93. doi: 10.1016/j.tim.2012.06.004. Epub 2012 Jul 20. Review.

PMID:
22819099
34.

Identification of genes that contribute to the pathogenesis of invasive pneumococcal disease by in vivo transcriptomic analysis.

Ogunniyi AD, Mahdi LK, Trappetti C, Verhoeven N, Mermans D, Van der Hoek MB, Plumptre CD, Paton JC.

Infect Immun. 2012 Sep;80(9):3268-78. doi: 10.1128/IAI.00295-12. Epub 2012 Jul 9.

35.

Identification of a novel pneumococcal vaccine antigen preferentially expressed during meningitis in mice.

Mahdi LK, Wang H, Van der Hoek MB, Paton JC, Ogunniyi AD.

J Clin Invest. 2012 Jun;122(6):2208-20. doi: 10.1172/JCI45850. Epub 2012 May 24.

36.

Hepatic induction of cholesterol biosynthesis reflects a remote adaptive response to pneumococcal pneumonia.

Weber M, Lambeck S, Ding N, Henken S, Kohl M, Deigner HP, Enot DP, Igwe EI, Frappart L, Kiehntopf M, Claus RA, Kamradt T, Weih D, Vodovotz Y, Briles DE, Ogunniyi AD, Paton JC, Maus UA, Bauer M.

FASEB J. 2012 Jun;26(6):2424-36. doi: 10.1096/fj.11-191957. Epub 2012 Mar 13.

PMID:
22415311
37.

Contribution of a genomic accessory region encoding a putative cellobiose phosphotransferase system to virulence of Streptococcus pneumoniae.

McAllister LJ, Ogunniyi AD, Stroeher UH, Paton JC.

PLoS One. 2012;7(2):e32385. doi: 10.1371/journal.pone.0032385. Epub 2012 Feb 21.

38.

A molecular mechanism for bacterial susceptibility to zinc.

McDevitt CA, Ogunniyi AD, Valkov E, Lawrence MC, Kobe B, McEwan AG, Paton JC.

PLoS Pathog. 2011 Nov;7(11):e1002357. doi: 10.1371/journal.ppat.1002357. Epub 2011 Nov 3.

39.

Contribution of serotype and genetic background to virulence of serotype 3 and serogroup 11 pneumococcal isolates.

McAllister LJ, Ogunniyi AD, Stroeher UH, Leach AJ, Paton JC.

Infect Immun. 2011 Dec;79(12):4839-49. doi: 10.1128/IAI.05663-11. Epub 2011 Sep 19.

40.

Deteriorating pneumococcal-specific B-cell memory in minimally symptomatic African children with HIV infection.

Iwajomo OH, Finn A, Moons P, Nkhata R, Sepako E, Ogunniyi AD, Williams NA, Heyderman RS.

J Infect Dis. 2011 Aug 15;204(4):534-43. doi: 10.1093/infdis/jir316.

PMID:
21791655
41.

Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood.

Harvey RM, Ogunniyi AD, Chen AY, Paton JC.

Infect Immun. 2011 Oct;79(10):4122-30. doi: 10.1128/IAI.05418-11. Epub 2011 Jul 25.

42.

Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease.

Trappetti C, Ogunniyi AD, Oggioni MR, Paton JC.

PLoS One. 2011;6(5):e19844. doi: 10.1371/journal.pone.0019844. Epub 2011 May 18.

43.

A variable region within the genome of Streptococcus pneumoniae contributes to strain-strain variation in virulence.

Harvey RM, Stroeher UH, Ogunniyi AD, Smith-Vaughan HC, Leach AJ, Paton JC.

PLoS One. 2011 May 5;6(5):e19650. doi: 10.1371/journal.pone.0019650.

44.

The conformation and function of a multimodular glycogen-degrading pneumococcal virulence factor.

Lammerts van Bueren A, Ficko-Blean E, Pluvinage B, Hehemann JH, Higgins MA, Deng L, Ogunniyi AD, Stroeher UH, El Warry N, Burke RD, Czjzek M, Paton JC, Vocadlo DJ, Boraston AB.

Structure. 2011 May 11;19(5):640-51. doi: 10.1016/j.str.2011.03.001.

45.

Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease.

Ota MO, Oluwalana C, Howie SR, Gomez M, Ogunniyi AD, Mendy-Gomez AL, Owolabi O, Mureithi MW, Townend J, Secka O, Antonio M, Sutherland JS, Adegbola RA.

Int J Infect Dis. 2011 Apr;15(4):e282-8. doi: 10.1016/j.ijid.2010.12.011. Epub 2011 Feb 16.

46.

Evicting the pneumococcus from its nasopharyngeal lodgings.

Paton JC, Ogunniyi AD.

Cell Host Microbe. 2011 Feb 17;9(2):89-91. doi: 10.1016/j.chom.2011.01.013.

47.

Central role of manganese in regulation of stress responses, physiology, and metabolism in Streptococcus pneumoniae.

Ogunniyi AD, Mahdi LK, Jennings MP, McEwan AG, McDevitt CA, Van der Hoek MB, Bagley CJ, Hoffmann P, Gould KA, Paton JC.

J Bacteriol. 2010 Sep;192(17):4489-97. doi: 10.1128/JB.00064-10. Epub 2010 Jul 2.

48.

Evaluation of biophotonic imaging to estimate bacterial burden in mice infected with highly virulent compared to less virulent Streptococcus pneumoniae serotypes.

Henken S, Bohling J, Ogunniyi AD, Paton JC, Salisbury VC, Welte T, Maus UA.

Antimicrob Agents Chemother. 2010 Aug;54(8):3155-60. doi: 10.1128/AAC.00310-10. Epub 2010 Jun 7.

49.

Efficacy profiles of daptomycin for treatment of invasive and noninvasive pulmonary infections with Streptococcus pneumoniae.

Henken S, Bohling J, Martens-Lobenhoffer J, Paton JC, Ogunniyi AD, Briles DE, Salisbury VC, Wedekind D, Bode-Böger SM, Welsh T, Bange FC, Welte T, Maus UA.

Antimicrob Agents Chemother. 2010 Feb;54(2):707-17. doi: 10.1128/AAC.00943-09. Epub 2009 Nov 16.

50.

Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H.

Ogunniyi AD, Grabowicz M, Mahdi LK, Cook J, Gordon DL, Sadlon TA, Paton JC.

FASEB J. 2009 Mar;23(3):731-8. doi: 10.1096/fj.08-119537. Epub 2008 Oct 29.

PMID:
18971260

Supplemental Content

Loading ...
Support Center